Clinical Trial Update: Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of disulfiram, copper gluconate, and temozolomide for unmethylated glioblastoma multiforme was terminated, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Copper gluconate (copper gluconate)
• Disulfiram (Disulfiram)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Glioblastoma, Glioblastoma Multiforme | Phase 2 | Status: TERMINATED | Results posted: 2023-09-08